Short interval between symptom onset and medical care as an indication of rapid onset of interstitial cystitis/painful bladder syndrome

被引:9
作者
Greenberg, Patty
Tracy, J. Kathleen
Meyer, Walter A.
Yates, Teresa
Diggs, Christina
Warren, John W. [1 ]
机构
[1] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA
关键词
interstitial cystitis; painful bladder syndrome; onset; PENTOSAN POLYSULFATE; CLINICAL-TRIAL; UPDATE; INDEX;
D O I
10.1111/j.1464-410X.2007.06989.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
To assess how many patients with interstitial cystitis/painful bladder syndrome (IC/PBlS) obtain medical care soon after symptom onset, and to determine how these patients differ from those who have medical care later. In a risk-factor study of IC/PBlS, we recruited women with IC/PBlS symptoms of <= 12 months' duration and carefully identified the onset date, first medical encounter and early clinical findings. Of 138 women with IC/PBlS for <= 12 months, 49% sought medical care within 7 days and another 31% within 4 weeks. These patients had no easier access to medical care but rather experienced symptoms differently, with more evidence for discomfort and inflammation. However, subsequently they did not differ from those with more gradual onset in features indicative of IC/PBlS, i.e. Hunner's ulcers, petechial haemorrhages, symptoms, medications, or quality of life. A shorter time to the first medical encounter was not a function of greater access to medical care but instead was associated with more discomfort and evidence of inflammation, as distinct from those with more gradual onset. The 6-month follow-up of both groups indicated that no significant differences in IC/PBlS symptoms persisted. A careful study of rapid-onset IC/PBlS might provide clues to the pathogenesis of this enigmatic disease.
引用
收藏
页码:599 / 602
页数:4
相关论文
共 15 条
  • [1] Assessing urgency in interstitial cystitis/painful bladder syndrome
    Diggs, Christina
    Meyer, Walter A.
    Langenberg, Patricia
    Greenberg, Patty
    Horne, Linda
    Warren, John W.
    [J]. UROLOGY, 2007, 69 (02) : 210 - 214
  • [2] Interstitial cystitis: Update on etiologies and therapeutic options
    Erickson, DR
    [J]. JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE, 1999, 8 (06): : 745 - 758
  • [3] CHRONIC INTERSTITIAL CYSTITIS - A HETEROGENEOUS SYNDROME
    FALL, M
    JOHANSSON, SL
    ALDENBORG, F
    [J]. JOURNAL OF UROLOGY, 1987, 137 (01) : 35 - 38
  • [4] INTERSTITIAL CYSTITIS - REPORT OF 223 CASES (204 WOMEN AND 19 MEN)
    HAND, JR
    [J]. JOURNAL OF UROLOGY, 1949, 61 (02) : 291 - 310
  • [5] Held PJ, 1990, Interstitial Cystitis, P29, DOI 10.1007/978-1-4471-3293-6_4
  • [6] Psychometric validation of the O'Leary-Sant Interstitial Cystitis Symptom Index in a clinical trial of pentosan polysulfate sodium
    Lubeck, DP
    Whitmore, K
    Sant, GR
    Alvarez-Horine, S
    Lai, CL
    [J]. UROLOGY, 2001, 57 (6A) : 62 - 66
  • [7] The interstitial cystitis symptom index and problem index
    OLeary, MP
    Sant, GR
    Fowler, FJ
    Whitmore, KE
    SpolarichKroll, J
    [J]. UROLOGY, 1997, 49 (5A) : 58 - 63
  • [8] ORAVISTO KJ, 1975, ANN CHIR GYNAECOL FE, V64, P75
  • [9] The management of interstitial cystitis: an update
    Phatak, S
    Foster, HE
    [J]. NATURE CLINICAL PRACTICE UROLOGY, 2006, 3 (01): : 45 - 53
  • [10] A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis
    Sant, GR
    Propert, KJ
    Hanno, PM
    Burks, D
    Culkin, D
    Diokno, AC
    Hardy, C
    Landis, JR
    Mayer, R
    Madigan, R
    Messing, EM
    Peters, K
    Theoharides, TC
    Warren, J
    Wein, AJ
    Steers, W
    Kusek, JW
    Nyberg, LM
    [J]. JOURNAL OF UROLOGY, 2003, 170 (03) : 810 - 815